← Leaderboards
Bita Moghaddam
Oregon Health & Science University
$15,386,487
Attributed
$15,386,487
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $980.6K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,386,487 · 12
By mechanism
R01$8,248,155 · 3
R37$3,430,389 · 1
R21$2,302,886 · 4
R56$491,244 · 1
P50$451,221 · 1
K02$421,892 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaBehaviorRattusNeuronsDopamineCognitiveEventAffectiveAnimalsBehavioralPrefrontal CortexAnimal ModelVentral Tegmental AreaRodentFunctional DisorderGlutamatesResponseNeurochemistryBasePharmaceutical PreparationsPresynapticNucleus AccumbensAntipsychotic AgentsLearning
Grant awards (56)
Neural basis of learning and response inhibition in adolescents$520,028
R01 · FY2025 · MH · contact PI
Neural basis of learning and response inhibition in adolescents$520,028
R01 · FY2024 · MH · contact PI
Long term consequences of adolescent alcohol use on behavioral inhibition$182,875
R21 · FY2024 · AA · contact PI
Neural basis of learning and response inhibition in adolescents$520,028
R01 · FY2023 · MH · contact PI
Long term consequences of adolescent alcohol use on behavioral inhibition$221,375
R21 · FY2023 · AA · contact PI
Neural basis of learning and response inhibition in adolescents$530,028
R01 · FY2022 · MH · contact PI
Reward Encoding and Anxiety$480,428
R01 · FY2021 · MH · contact PI
Reward Encoding and Anxiety$480,428
R01 · FY2020 · MH · contact PI
Reward Encoding and Anxiety$480,428
R01 · FY2019 · MH · contact PI
Reward Encoding and Anxiety$505,714
R01 · FY2018 · MH · contact PI
Inhibitory Control of Prefrontal Cortex$491,244
R56 · FY2017 · MH · contact PI
Neurochemical basis of antipsychotic drugs$385,000
R01 · FY2017 · MH · contact PI
Neurochemical basis of antipsychotic drugs$254,129
R01 · FY2016 · MH · contact PI
Neurochemical basis of antipsychotic drugs$166,552
R01 · FY2016 · MH · contact PI
Neurochemical basis of antipsychotic drugs$46,454
R01 · FY2016 · MH · contact PI
Neurochemical basis of antipsychotic drugs$374,737
R01 · FY2015 · MH · contact PI
Neurochemical basis of antipsychotic drugs$374,737
R01 · FY2014 · MH · contact PI
Neurochemical basis of antipsychotic drugs$371,272
R01 · FY2013 · MH · contact PI
Inhibitory Control of Prefrontal Cortex$350,234
R01 · FY2013 · MH · contact PI
Fatty Acids and Preclinical Models of Psychiatric Disorders$216,677
R21 · FY2013 · MH · contact PI
Neurochemical Effects of Antipsychotic Drugs$373,599
R37 · FY2012 · MH · contact PI
Inhibitory Control of Prefrontal Cortex$364,827
R01 · FY2012 · MH · contact PI
Fatty Acids and Preclinical Models of Psychiatric Disorders$187,830
R21 · FY2012 · MH · contact PI
Neurochemical Effects of Antipsychotic Drugs$428,771
R37 · FY2011 · MH · contact PI
Inhibitory Control of Prefrontal Cortex$364,827
R01 · FY2011 · MH · contact PI
Neurochemical Effects of Antipsychotic Drugs$377,373
R37 · FY2010 · MH · contact PI
Inhibitory Control of Prefrontal Cortex$368,512
R01 · FY2010 · MH · contact PI
Neurochemical Effects of Antipsychotic Drugs$55,730
R37 · FY2010 · MH · contact PI
Inhibitory Control of Prefrontal Cortex$381,387
R01 · FY2009 · MH · contact PI
Neurochemical Effects of Antipsychotic Drugs$377,373
R37 · FY2009 · MH · contact PI
Cannabinoid Approaches for Treatment of Tourette's Syndrome$221,877
R21 · FY2009 · MH · contact PI
Neurochemical Effects of Antipsychotic Drugs$377,373
R37 · FY2008 · MH · contact PI
Cannabinoid Approaches for Treatment of Tourette's Syndrome$184,752
R21 · FY2008 · MH · contact PI
Neurochemical Effects of Antipsychotic Drugs$103,331
R37 · FY2008 · MH · contact PI
Neurochemical Effects of Antipsychotic Drugs$276,867
R37 · FY2007 · MH · contact PI
Neurochemical Effects of Antipsychotic Drugs$285,136
R37 · FY2006 · MH · contact PI
Neurochemical Effects of Antipsychotic Drugs$1
R37 · FY2005 · MH
Neurochemical Effects of Antipsychotic Drugs$291,998
R37 · FY2004 · MH
Translational Studies on Cognitive Flexibility$286,857
R21 · FY2003 · MH
Neurochemical Effects of Antipsychotic Drugs$247,204
R37 · FY2003 · MH
GLUTAMATE AND PREFRONTAL CORTEX FUNCTION$80,259
K02 · FY2003 · MH
Translational Studies on Cognitive Flexibility$75,643
R21 · FY2003 · MH
Glumate and Disorders of Cognition and Motivation$40,700
R13 · FY2003 · MH
GLUTAMATE AND PREFRONTAL CORTEX FUNCTION$25,214
K02 · FY2003 · MH
Neurochemical Effects of Antipsychotic Drugs$7,433
R37 · FY2003 · MH
Translational Studies on Cognitive Flexibility$362,500
R21 · FY2002 · MH
Neurochemical Effects of Antipsychotic Drugs$228,200
R37 · FY2002 · MH
GLUTAMATE AND PREFRONTAL CORTEX FUNCTION$105,473
K02 · FY2002 · MH
GLUTAMATERGIC MECHANISMS IN COGNITION AND PSYCHOSIS$73,467
P50 · FY2002 · MH
Translational Studies on Cognitive Flexibility$362,500
R21 · FY2001 · MH
NEUROCHEMICAL EFFECTS OF ANTIPSYCHOTIC DRUGS$207,188
R01 · FY2001 · MH
GLUTAMATE AND PREFRONTAL CORTEX FUNCTION$105,473
K02 · FY2001 · MH
GLUTAMATERGIC MECHANISMS IN COGNITION AND PSYCHOSIS$73,467
P50 · FY2001 · MH
GLUTAMATERGIC MECHANISMS IN COGNITION AND PSYCHOSIS$304,287
P50 · FY2000 · MH
NEUROCHEMICAL EFFECTS OF ANTIPSYCHOTIC DRUGS$201,189
R01 · FY2000 · MH
GLUTAMATE AND PREFRONTAL CORTEX FUNCTION$105,473
K02 · FY2000 · MH